Acadian Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Acadian Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-27,972	Closed	-$936K	–	1654
2017 Q2	$936K	Sell	27,972 -254,243	-90%	-$7.58M	﹤0.01%	718
2017 Q1	$8.17M	Sell	282,215 -285,376	-50%	-$7.07M	0.04%	327
2016 Q4	$12.7M	Sell	567,591 -30,612	-5%	-$598K	0.06%	252
2016 Q3	$11.1M	Buy	598,203 +230,675	+63%	+$4.35M	0.06%	257
2016 Q2	$5.99M	Buy	+367,528	New	+$5.41M	0.03%	335
2015 Q3	–	Sell	-8,597	Closed	-$81K	–	1584
2015 Q2	$81K	Sell	8,597 -17,812	-67%	-$165K	﹤0.01%	1042
2015 Q1	$234K	Buy	26,409 +22,346	+550%	+$226K	﹤0.01%	895
2014 Q4	$41K	Buy	+4,063	New	+$34.8K	﹤0.01%	1062
2014 Q2	–	Sell	-3,617	Closed	-$36K	–	1109
2014 Q1	$36K	Buy	+3,617	New	+$33.3K	﹤0.01%	896
2013 Q4	–	Sell	-4,426	Closed	-$44K	–	1175
2013 Q3	$44K	Buy	+4,426	New	+$34.8K	﹤0.01%	885

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management's BEAT Position: Q3 2017 in Review

Acadian Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2017, closing a stake of 27,972 shares — an estimated $936K sold.

Acadian Asset Management first reported a position in BEAT in Q3 2013 and held it in 10 quarters. The position peaked at $12.7M in Q4 2016. 211 funds tracked by Wall St. Rank hold BEAT as of Q3 2017.

Acadian Asset Management reported no remaining BioTelemetry, Inc. position as of Q3 2017 after selling out during the quarter.
Acadian Asset Management sold 27,972 BioTelemetry, Inc. shares in Q3 2017, an estimated $936K.
Acadian Asset Management first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 10 quarters.
Acadian Asset Management's BioTelemetry, Inc. position peaked at $12.7M in Q4 2016.
211 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2017.

Based on Acadian Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.